# ARISE - Aggressive Reduction of Inflammation Stops Events

> **NCT00066898** · PHASE3 · UNKNOWN · sponsor: **AtheroGenics** · enrollment: 6000 (—)

## Conditions studied

- Atherosclerosis
- Coronary Artery Disease
- Myocardial Infarction
- Unstable Angina

## Interventions

- **DRUG:** AGI-1067

## Key facts

- **NCT ID:** NCT00066898
- **Lead sponsor:** AtheroGenics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2003-06
- **Primary completion:** —
- **Final completion:** 2006-12
- **Target enrollment:** 6000 (—)
- **Last updated:** 2006-10-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00066898

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00066898, "ARISE - Aggressive Reduction of Inflammation Stops Events". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00066898. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*